1. 160 Implementation of serious illness care programme uk for patients with advanced cancer: feasibility study. Issue Volume 8: Issue (2018)Supplement 1 (1st March 2018) Authors: McGlinchey, Tamsin; Mason, Stephen; Coackley, Alison; Roberts, Anita; Maguire, Maria; Sanders, Justin; Maloney, Francine; Block, Susan; Ellershaw, John; Kirkbride, Peter Journal: BMJ supportive & palliative care Issue: Volume 8: Issue (2018)Supplement 1 Page Start: A68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase II trial of cabazitaxel as second line chemotherapy in relapsed locally advanced and/or metastatic carcinoma of the penis. Issue 10 (October 2019) Authors: Challapalli, Amarnath; Pearson, Sylvia; Mitra, Anita V.; Coe, Marc; Thomson, Alastair; Elliott, Tony; Kirkbride, Peter; Pickering, Lisa; Kirk, Hannah; Foulstone, Emily; Evans, Heidi; Bravo, Alicia; Bahl, Amit K. Journal: Journal of international medical research Issue: Volume 47:Issue 10(2019) Page Start: 4664 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial. Issue 8 (August 2016) Authors: Dearnaley, David; Syndikus, Isabel; Mossop, Helen; Khoo, Vincent; Birtle, Alison; Bloomfield, David; Graham, John; Kirkbride, Peter; Logue, John; Malik, Zafar; Money-Kyrle, Julian; O'Sullivan, Joe M; Panades, Miguel; Parker, Chris; Patterson, Helen; Scrase, Christopher; Staffurth, John; Stockdale... Journal: Lancet oncology Issue: Volume 17:Issue 8(2016:Aug.) Page Start: 1047 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial. Issue 16 (December 2015) Authors: Wilkins, Anna; Mossop, Helen; Syndikus, Isabel; Khoo, Vincent; Bloomfield, David; Parker, Chris; Logue, John; Scrase, Christopher; Patterson, Helen; Birtle, Alison; Staffurth, John; Malik, Zafar; Panades, Miguel; Eswar, Chinnamani; Graham, John; Russell, Martin; Kirkbride, Peter; O'Sullivan, Joe ... Journal: Lancet oncology Issue: Volume 16:Issue 16(2015) Page Start: 1605 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗